Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Intangibles (2016 - 2022)

Historic Intangibles for Abeona Therapeutics (ABEO) over the last 11 years, with Q3 2022 value amounting to $2.2 million.

  • Abeona Therapeutics' Intangibles changed 0.0% to $2.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.2 million for FY2021, which is 0.0% changed from last year.
  • Abeona Therapeutics' Intangibles amounted to $2.2 million in Q3 2022, which was down 0.0% from $2.2 million recorded in Q2 2022.
  • Abeona Therapeutics' 5-year Intangibles high stood at $44.9 million for Q4 2018, and its period low was $2.2 million during Q4 2020.
  • For the 5-year period, Abeona Therapeutics' Intangibles averaged around $11.6 million, with its median value being $2.6 million (2020).
  • In the last 5 years, Abeona Therapeutics' Intangibles skyrocketed by 104624.7% in 2019 and then tumbled by 9388.35% in 2020.
  • Abeona Therapeutics' Intangibles (Quarter) stood at $44.9 million in 2018, then decreased by 5.02% to $42.6 million in 2019, then crashed by 94.94% to $2.2 million in 2020, then changed by 0.0% to $2.2 million in 2021, then changed by 0.0% to $2.2 million in 2022.
  • Its Intangibles was $2.2 million in Q3 2022, compared to $2.2 million in Q2 2022 and $2.2 million in Q1 2022.